Your session is about to expire
← Back to Search
BreEStim for Pain Management
Study Summary
This trial will compare two electrical stimulations for phantom limb pain after amputation.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is this research endeavor actively seeking participants at the present time?
"This clinical trial is actively seeking enrollees, with the initial posting on April 2nd 2021 and most recent update occurring on April 23rd 2022. This information can be found in detail at clinicaltrials.gov."
How many participants has the research group enlisted for this trial?
"Affirmative. Per the information posted on clinicaltrials.gov, this experiment is still in search of participants and was first published on April 2nd 2021 with its latest update occurring on April 23rd 2022. The researchers are currently looking for 14 individuals across one medical centre to partake in the study."
How may I apply to be part of this research initiative?
"This clinical trial is seeking 14 participants who are aged between 18 and 75, and have suffered from chronic pain that has lasted for more than three months. Additionally, they must be experiencing phantom limb pain after amputation of an upper or lower extremity without having made any alterations to their current oral medication regimen in the past two weeks."
Does this trial offer participation to any individuals younger than 75 years old?
"According to the study's criteria, only individuals aged 18 - 75 are eligible for participation. Additionally, there are two separate studies available targeting minors and 52 trials developed specifically with seniors in mind."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
How responsive is this trial?
Typically responds via
Most responsive sites:
- The University of Texas Health Science Center: < 48 hours
Average response time
- < 2 Days
Share this study with friends
Copy Link
Messenger